US Authorizes New Antibody Drug to Fight Omicron

Published on February 11, 2022

U.S. health regulators on Friday authorized a new antibody drug that targets the omicron variant, a key step in restocking the nation’s arsenal against the latest version of COVID-19.

Read Full Article (External Site)